Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $8.78 million versus the consensus estimate of $6.88 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.